What are the benefits of using inodilators like levosimendan in managing septic shock in critically ill patients?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18399445
Cited by: 0

Abstract

Levosimendan shows some promise in improving hemodynamic and metabolic parameters in septic shock, but evidence regarding its impact on mortality and ICU stay is inconclusive.

Fields of Study & Subjects

Sepsis Diagnosis and Treatment Hemodynamic Monitoring and Therapy Heart Failure Treatment and Management

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
28 January 2026